The effect of Tanshinone IIA on the expression of NF-κBinverted commasIκB-α and the mRNA of ICAM-1 and VCAM-1 of ECV304 induced by TNF-α

Chinese Pharmacological Bulletin

Volumn 23, Issue 12, 2007, Pages

  Cui, Guang Zhi ^a   Jin, Shu Mei ^b   Zhao, Gui Feng ^a   Fan, Ying Chang ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b TIANJIN HUANHU HOSPITAL   (China)

Author keywords

Adhesion molecule; ECV304; mRNA; NF B; Tanshinone IIA

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; TANSHINONE; TANSHINONE 2A; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL DAMAGE; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; DRUG TARGETING; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PLANT ROOT; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN;

EID: 38349186247     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Braun M, Pietsch P, Zepp A, et al. Felix. Regulation of tumor necrosis factor-and interleukin-1β induced adhesion molecule expression in human vascular smooth muscle cells by cAMP[J]. Arteri Thrombo Vasc Biol, 1997,17:2568-75.
2. Yah C H, Sturgis L, Haidacher J, et al. Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion [J]. Diabetes, 2001,50(6):1495-504.
3. Esteban V, Ruperez M, Sanchez-Lopez E, et al. Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells[J]. Circ Res, 2005,96(9):965-73.
4. Lerman A, Edwards B S, Hallett J W, et al. Circulation and tissue endothelin immunoreactivity in advanced atherosclerosis[J]. N Eng Med, 1991,325(14):997-1001.
5. Hu Y W, Wang S C, Li Z. Effects of Tanshinone II A on LSP-induced hepatocyte injury and cytokines-secreting of by kupffer cells[J]. Chin Pharmacol Bull, 2005,21(12):1482-6.
6. Tsao P S, Cooke J P. Endothelial alterations in hypercholesterolemia: more than simply vasodilator dysfunction[J]. J Cardiovasc Pharm, 1998,32(suppl 3):S48-53.
7. Tang Y, Tao X, Tang C. Role of ET in thrombolysis in rat abdominal aorta[J]. J Cardiovasc Pharm, 1998,31(suppl 1):s470-2.
8. Jiang F L, Feng J, Zheng Z. Effects of tanshinone II on the mR-NA expression of c-fosinverted commasc-myc and c-jun in angiotensin II-induced hypertrophy of cardiomyocytes[J]. Chin Pharmacol Bull, 2001,23(1):55-9.
9. Desideri G, Croce G, Tucci M, et al. Effects of bezafibrate and simvastatin on endothelial activation and lipid peroxidation in hypercholesterolemia: evidence of different vascular protection by different lipid-lowering treatments[J]. J Clin Endocrinol Metab, 2003,88(11):5341-7.
10. Saito S, Hirata Y, Emori T, et al. Angiotensin II activates endothelial constitutive nitric oxide synthase via AT1 receptors[J]. Hypertens Res, 1996,19(3):201-6.
11. Stefanie D, Volker R, Weiland U, et al. Angiotensin II induces apopsis of human endothelial cell[J]. Circ Res, 1997,81:970-6.